Publication: 3319

Publication: 3319

Genetic predictors of severe skin toxicity in stage III colon cancer patients treated with cetuximab: NCCTG N0147 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Cancer Epidemiol Biomarkers Prev vol 30 (2) 404-411

Year:: 2021
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: Alliance-data-source,-external-user
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 10

Parents:: None
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:

Pharmas:: Genentech, Sanofi, Pfizer, Eli Lilly and Company
Grants:: U10CA180821, U10CA180882, U24CA196171, R01CA176272, UG1CA233180, UG1CA233339, UG1CA189858, T32 CA094880, K05 CA152715

Corr. Author:
Authors:: Julia D. Labadie Xinwei Hua Tabitha A. Harrison Barbara L. Banbury Jeroen R. Huyghe Wei Sun Qian Shi Greg Yothers Steven R. Alberts Frank A. Sinicrope Richard M. Goldberg Thomas J. George Kathryn L. Penney Amanda I. Phipps Stacey A. Cohen Ulrike Peters Andrew T. Chan Polly A. Newcomb

Networks:: LAPS-MN026, LAPS-OH007

Study: Alliance-A151904
Multiple Studies, or Legacy Studies in Alliance Study:: NCCTG-N0147
Phases:: N/A, 3

Keywords:: genetics, colon cancer, chemotherapy, rash